Abstract:Background While chemo-radiotherapy improves local control in patients with locally advanced rectal cancer, it can also increase acute hematological toxicity (HT), which leads to poor outcomes. Patients receiving bone marrow radiation have been shown to develop acute HT. However, the safety and efficacy of bone marrow sparing is undetermined. The aim of our study was to explore the feasible dosimetric constraints for pelvic bone marrow (PBM) that can be widely used in rectal cancer patients undergoing chemo-radiotherapy. Methods 112 rectal cancer patients were selected and divided into the PBM sparing IMRT group (60 cases) and the non-PBM sparing IMRT group (52 cases). All patients underwent pelvic radiotherapy with concurrent capecitabine-based chemotherapy. The PBM dosimetric constraints in the PBM sparing IMRT group were set to:V 10 ≤ 85%, V 20 ≤ 65% and V 30 ≤ 45%. An independent sample t test was applied for the dose-volume parameters, and Chi-squared analysis was applied for clinical parameters and adverse events. Results The radiation dose to PBM (V 5 ~V 45 , D mean , P <0.05), PBM sub-regions (V 10 ~V 35 , D mean , P <0.05) and both femoral heads (V 5 ~V 40 , D mean , P <0.05) decreased significantly in the PBM sparing IMRT group compared with that of the non-PBM sparing IMRT group ( P <0.05). There was no significant difference in any dose-volume parameters of the bladder and small bowel in either groups, and none in the planning target volume (PTV) dose homogeneity and conformity ( P >0.05). For acute HT observation, the incidence of grade 3 acute HT (χ 2 = 7.094, P =0.008) was significantly reduced in patients treated with PBM sparing IMRT compared with patients treated with non-PBM sparing IMRT. There was no statistical difference in the incidence of vomiting, diarrhea, fatigue, anorexia, nausea, hand-foot syndrome, cystitis, perianal pain and perianal dermatitis in patients of both groups ( P > 0.05). Conclusions Applying PBM dosimetric constraints (V 10 ≤ 85%, V 20 ≤ 65% and V 30 ≤ 45%) can significantly reduce the radiation dose to PBM. The patients treated with PBM sparing IMRT had a lower incidence of acute HT compared with those treated with non-PBM sparing IMRT. Applying the PBM dosimetric constraints proposed by our study can benefits the patients with rectal cancer undergoing capecitabine-based chemo-radiotherapy.

Very pronounced bowel sparing during radiation therapy for anal carcinoma using a natural spacer (Myoma) – a case report

The role of radioprotective spacers in clinical practice: a review

Immobilization-assisted Abdominal Deep Inspiration Breath-Hold in Post-Mastectomy Radiotherapy of Left-Sided Breast Cancer with Internal Mammary Chain Coverage

Reduction in rectal doses of pelvic radiotherapy with excessive rectal gas extraction: a single-institution case report

Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer

Preoperative Radiotherapy For Patients With Rectal Cancer: A Risk Factor For Non-Reversal Of Ileostomy Caused By Stenosis Or Stiffness Proximal To Colorectal Anastomosis

Laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for locally advanced ultra-low rectal cancer

Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer

Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer

Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity

Perianal leiomyosarcoma as a rare sequela of rectal cancer radiotherapy: a case report

Laparoscopic polyglycolic acid spacer placement for locally recurrent rectal cancer

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review

Prostate cancer invading rectal serosa and anal sphincter treated with definitive radiation therapy: Case report and review of the literature

Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy

Precision assessment of bowel motion quantification using 3D cine-MRI for radiotherapy

P2.47: Minimizing Intestinal Resection Strategy for Prevention of Short Bowel Syndrome in Surgery for Chronic Radiation Enteritis: Shanghai Experience

Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system

Successful treatment of an enormous rectal mucosa-associated lymphoid tissue lymphoma by endoscopic full-thickness resection: A case report

A retrospective analysis to compare the dosimetric parameters of two rectum–sparing techniques during intracavitary brachytherapy with tandem–ring applicators for cervical cancer

Challenges associated with low rectal malignant obstruction stenting: a case report